Clinical Trial

Evaluating the Occurrence of DKA in People With Type I Diabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.
Trial Details
NCT Number NCT07739342
Lead Sponsor Abbott Diabetes Care
Conditions Type 1 Diabetes
Enrollment 1,200 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-31